US 11713446
Processes for generating TIL products enriched for tumor antigen-specific T-cells
granted A61KA61K2239/57A61K35/17
Quick answer
US patent 11713446 (Processes for generating TIL products enriched for tumor antigen-specific T-cells) held by Iovance Biotherapeutics, Inc. expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2239/57, A61K35/17, A61K40/11, A61K40/428